Lung tumors
Conditions
Interventions
Continuous epidural infusion with ropivacaine 0.15% plus fentanyl 2.5 microgram/ml at a dose of 4 ml/h to patients till next morning after video-assisted thoracoscopic surgery for lung tumors.
Program
Sponsors
Sumitomo Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing video-assisted thoracoscopic surgery under general and epidural anesthesia, who are scheduled to be admitted to the ICU after surgery.
Exclusion criteria
Exclusion criteria: 1) An American Society of Anesthesiologists Physical status of more than 3. 2) A patient who has a history of allergies or intolerance to local anesthetics or fentanyl. 3) A patient undergoing surgery without epidural anesthesia. 4) A patient undergoing another surgical procedure in combination with video-assisted thoracoscopic surgery. 5) A patient of less than height 150cm. 6) A patient who does not agree to participate this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale of postoperative pain at rest and with coughing shortly, 1, 2, and 4 hours after admission to the ICU, | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Extent of cold and pain sensory blockade on the first postoperative day. 2) Patient satisfaction 3) Occurrence of complications such as hypotension, bradycardia, hypopnea, nausea, and vomiting. 4) Frequency of patient controlled analgesia (PCA). 5) Total amount of rescue analgesic medication. | — |
Countries
Japan
Contacts
Public ContactArisa Hotta
Sumitomo Hospital Department of Anesthesiology
Outcome results
None listed